FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1615-1617 November 14, 2002 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Ridker, P. M. PubMed Citation

Prediction is very difficult, especially about the future.

— Niels Bohr

More than 20 years ago, 246 risk factors for coronary heart disease (CHD) had already been identified, and the number continues to grow.¹ Advances in genomics and proteomics will provide even more candidate markers to consider for routine assessment in practice. Risk stratification is important because information about the probability of a cardiovascular event in the future can help target therapy and resources to those most likely to benefit. Of the several hundred known correlates of CHD, only a handful have had the staying power to be recommended for . . . [Full Text of this Article]

This article has been cited by other articles:

• Wilson, P. W.F. (2008). Progressing From Risk Factors to Omics. Circ Cardiovasc Genet 1: 141-146 [Full Text]  
• Louden, C., Brott, D., Katein, A., Kelly, T., Gould, S., Jones, H., Betton, G., Valetin, J.-P., Richardson, R. J. (2006). Biomarkers and Mechanisms of Drug-Induced Vascular Injury in Non-Rodents. Toxicol Pathol 34: 19-26 [Abstract] [Full Text]  
• Wilson, P. W. F., Nam, B.-H., Pencina, M., D'Agostino, R. B. Sr, Benjamin, E. J., O'Donnell, C. J. (2005). C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study. Arch Intern Med 165: 2473-2478 [Abstract] [Full Text]  
• Griffin, M. P., Lake, D. E., Bissonette, E. A., Harrell, F. E. Jr, O'Shea, T. M., Moorman, J. R. (2005). Heart Rate Characteristics: Novel Physiomarkers to Predict Neonatal Infection and Death. Pediatrics 116: 1070-1074 [Abstract] [Full Text]  
• Kullo, I. J., Ballantyne, C. M. (2005). Conditional Risk Factors for Atherosclerosis. Mayo Clin Proc. 80: 219-230 [Abstract]  
• Meagher, E. A. (2004). Addressing Cardiovascular Disease in Women: Focus on Dyslipidemia. J Am Board Fam Med 17: 424-437 [Abstract] [Full Text]  
• Levinson, S. S., Miller, J. J., Elin, R. J. (2004). Poor Predictive Value of High-Sensitivity C-Reactive Protein Indicates Need for Reassessment. Clin. Chem. 50: 1733-1735 [Full Text]  
• Paoletti, R., Gotto, A. M. Jr, Hajjar, D. P. (2004). Inflammation in Atherosclerosis and Implications for Therapy. Circulation 109: III-20-III-26 [Abstract] [Full Text]  
• von Eckardstein, A. (2004). Is there a need for novel cardiovascular risk factors?. Nephrol Dial Transplant 19: 761-765 [Full Text]  
• Hankey, G. J, Eikelboom, J. W (2004). Aspirin resistance. BMJ 328: 477-479 [Full Text]  
• Fonseca, V., Desouza, C., Asnani, S., Jialal, I. (2004). Nontraditional Risk Factors for Cardiovascular Disease in Diabetes. Endocr. Rev. 25: 153-175 [Abstract] [Full Text]  
• Backes, J. M, Howard, P. A, Moriarty, P. M (2004). Role of C-Reactive Protein in Cardiovascular Disease. The Annals of Pharmacotherapy 38: 110-118 [Abstract] [Full Text]  
• Greenland, P., Knoll, M. D., Stamler, J., Neaton, J. D., Dyer, A. R., Garside, D. B., Wilson, P. W. (2003). Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events. JAMA 290: 891-897 [Abstract] [Full Text]  
• Hackam, D. G., Anand, S. S. (2003). Emerging Risk Factors for Atherosclerotic Vascular Disease: A Critical Review of the Evidence. JAMA 290: 932-940 [Abstract] [Full Text]  
• Stenvinkel, P., Pecoits-Filho, R., Lindholm, B. (2003). Coronary Artery Disease in End-Stage Renal Disease: No Longer a Simple Plumbing Problem. J. Am. Soc. Nephrol. 14: 1927-1939 [Full Text]  
• Futterman, L. G., Lemberg, L. (2003). A Quick Test Predicts Acute Coronary Events. Am J Crit Care 12: 262-266 [Full Text]  
• Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O. III, Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., Rifai, N., Smith, S. C. Jr, Taubert, K., Tracy, R. P., Vinicor, F. (2003). Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107: 499-511 [Full Text]  
• (2002). CRP vs. LDL for Predicting Cardiovascular Risk. Journal Watch Cardiology 2002: 1-1 [Full Text]  
• (2002). CRP vs. LDL for Predicting Cardiovascular Risk. JWatch General 2002: 1-1 [Full Text]